Search for the latest updates on diabetes
News
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes Zacks via Yahoo! Finance - 51 minutes
Novo Nordisk A/S (NVO) announced data from new analyses of the phase IIIa DUAL studies (DUAL I and DUAL II) on Xultophy. Data showed that ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment